C3 and polycystic ovary syndrome: However, kaempferol and progesterone treatment both decreased C3 transcript expression, which is shown to be upregulated along with other complementary pathway factors in patients with PCOS and is thought to contribute to the inflammatory aspect of the disease [63,64].